Secukinumab does not show greater clinical efficacy than placebo in patients with moderate-to-severe Graves’ orbitopathy, according to the ORBIT study.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/secukinumab-fails-show-benefit-graves-orbitopathy-2025a1000yyx?src=rss
Author :
Publish date : 2025-12-16 12:00:00
Copyright for syndicated content belongs to the linked Source.